REPORT ID 4795

EMEA (Europe, Middle East and Africa) Animal Plasma and Derivatives Market Report 2017

Publish Date
19-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Animal Plasma and Derivatives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Animal Plasma and Derivatives for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Animal Plasma and Derivatives market competition by top manufacturers/players, with Animal Plasma and Derivatives sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Proliant Inc.
    Thermo Fisher Scientific, Inc.
    Merck KGaA
    Kraeber & Co GmbH
    LAMPIRE Biological Laboratories, Inc.
    Lake Immunogenics, Inc.
    Rocky Mountain Biologicals Inc.
    ANZCO Foods Ltd.
    Auckland BioSciences Ltd.
    Bovogen Biologicals Pty Ltd.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    By Derivatives Type
        Immunoglobulin
        Fibrinogen
        Serum Albumin
        Fetal Bovine Serum
        Thrombin
        New Born Calf Serum
    By Animal Type
        Bovine
        Ovine
        Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Food & Beverages
    Pharmaceuticals
    Cosmetics
    Feed
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Animal Plasma and Derivatives Market Report 2017
1 Animal Plasma and Derivatives Overview
    1.1 Product Overview and Scope of Animal Plasma and Derivatives
    1.2 Classification of Animal Plasma and Derivatives
        1.2.1 EMEA Animal Plasma and Derivatives Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Animal Plasma and Derivatives Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Immunoglobulin
        1.2.4 Fibrinogen
        1.2.5 Serum Albumin
        1.2.6 Fetal Bovine Serum
        1.2.7 Thrombin
        1.2.8 New Born Calf Serum
    1.3 EMEA Animal Plasma and Derivatives Market by Application/End Users
        1.3.1 EMEA Animal Plasma and Derivatives Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Food & Beverages
        1.3.3 Pharmaceuticals
        1.3.4 Cosmetics
        1.3.5 Feed
        1.3.6 Others
    1.4 EMEA Animal Plasma and Derivatives Market by Region
        1.4.1 EMEA Animal Plasma and Derivatives Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Animal Plasma and Derivatives (2012-2022)
        1.5.1 EMEA Animal Plasma and Derivatives Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Animal Plasma and Derivatives Revenue and Growth Rate (2012-2022)

2 EMEA Animal Plasma and Derivatives Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Animal Plasma and Derivatives Market Competition by Players/Manufacturers
        2.1.1 EMEA Animal Plasma and Derivatives Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Animal Plasma and Derivatives Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Animal Plasma and Derivatives Sale Price by Players (2012-2017)
    2.2 EMEA Animal Plasma and Derivatives (Volume and Value) by Type/Product Category
        2.2.1 EMEA Animal Plasma and Derivatives Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Animal Plasma and Derivatives Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Animal Plasma and Derivatives Sale Price by Type (2012-2017)
    2.3 EMEA Animal Plasma and Derivatives (Volume) by Application
    2.4 EMEA Animal Plasma and Derivatives (Volume and Value) by Region
        2.4.1 EMEA Animal Plasma and Derivatives Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Animal Plasma and Derivatives Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Animal Plasma and Derivatives Sales Price by Region (2012-2017)

3 Europe Animal Plasma and Derivatives (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Animal Plasma and Derivatives Sales and Value (2012-2017)
        3.1.1 Europe Animal Plasma and Derivatives Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Animal Plasma and Derivatives Revenue and Growth Rate (2012-2017)
    3.2 Europe Animal Plasma and Derivatives Sales and Market Share by Type
    3.3 Europe Animal Plasma and Derivatives Sales and Market Share by Application
    3.4 Europe Animal Plasma and Derivatives Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Animal Plasma and Derivatives Sales Volume by Countries (2012-2017)
        3.4.2 Europe Animal Plasma and Derivatives Revenue by Countries (2012-2017)
        3.4.3 Germany Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        3.4.4 France Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        3.4.5 UK Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        3.4.6 Russia Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        3.4.7 Italy Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)

4 Middle East Animal Plasma and Derivatives (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Animal Plasma and Derivatives Sales and Value (2012-2017)
        4.1.1 Middle East Animal Plasma and Derivatives Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Animal Plasma and Derivatives Revenue and Growth Rate (2012-2017)
    4.2 Middle East Animal Plasma and Derivatives Sales and Market Share by Type
    4.3 Middle East Animal Plasma and Derivatives Sales and Market Share by Application
    4.4 Middle East Animal Plasma and Derivatives Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Animal Plasma and Derivatives Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Animal Plasma and Derivatives Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        4.4.4 Israel Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        4.4.5 UAE Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        4.4.6 Iran Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)

5 Africa Animal Plasma and Derivatives (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Animal Plasma and Derivatives Sales and Value (2012-2017)
        5.1.1 Africa Animal Plasma and Derivatives Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Animal Plasma and Derivatives Revenue and Growth Rate (2012-2017)
    5.2 Africa Animal Plasma and Derivatives Sales and Market Share by Type
    5.3 Africa Animal Plasma and Derivatives Sales and Market Share by Application
    5.4 Africa Animal Plasma and Derivatives Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Animal Plasma and Derivatives Sales Volume by Countries (2012-2017)
        5.4.2 Africa Animal Plasma and Derivatives Revenue by Countries (2012-2017)
        5.4.3 South Africa Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Animal Plasma and Derivatives Sales and Growth Rate (2012-2017)

6 EMEA Animal Plasma and Derivatives Manufacturers/Players Profiles and Sales Data
    6.1 Proliant Inc.
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Proliant Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Thermo Fisher Scientific, Inc.
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Thermo Fisher Scientific, Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck KGaA
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck KGaA Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Kraeber & Co GmbH
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Kraeber & Co GmbH Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 LAMPIRE Biological Laboratories, Inc.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 LAMPIRE Biological Laboratories, Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Lake Immunogenics, Inc.
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Lake Immunogenics, Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Rocky Mountain Biologicals Inc.
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Rocky Mountain Biologicals Inc. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 ANZCO Foods Ltd.
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 ANZCO Foods Ltd. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Auckland BioSciences Ltd.
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Auckland BioSciences Ltd. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Bovogen Biologicals Pty Ltd.
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Animal Plasma and Derivatives Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Bovogen Biologicals Pty Ltd. Animal Plasma and Derivatives Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Animal Plasma and Derivatives Manufacturing Cost Analysis
    7.1 Animal Plasma and Derivatives Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Animal Plasma and Derivatives

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Animal Plasma and Derivatives Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Animal Plasma and Derivatives Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Animal Plasma and Derivatives Market Forecast (2017-2022)
    11.1 EMEA Animal Plasma and Derivatives Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Animal Plasma and Derivatives Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Animal Plasma and Derivatives Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Animal Plasma and Derivatives Price and Trend Forecast (2017-2022)
    11.2 EMEA Animal Plasma and Derivatives Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Animal Plasma and Derivatives Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Animal Plasma and Derivatives Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Animal Plasma and Derivatives Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Animal Plasma and Derivatives Sales Forecast by Type (2017-2022)
    11.7 EMEA Animal Plasma and Derivatives Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer